Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (131-140 of 548) with videos related to

Pageof 55
Sort By:
The Oncologist|January 23, 2025
Ovarian clear cell carcinoma: open questions on the management and treatment algorithmRoberta Rosso, Margherita Turinetto, Fulvio Borella, et al.
Plos One|June 9, 2022
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopeniaGerald A Soff, Isabelle Ray-Coquard, Luis J Marfil Rivera, et al.
Bulletin Du Cancer|January 20, 2012
First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancerJulien Peron, Olivier Tredan, Isabelle Ray-Coquard, et al.
Bulletin Du Cancer|November 23, 2011
[Renal insufficiency and breast cancer]Philippe Beuzeboc, Christophe Le Tourneau, Joseph Gligorov, et al.
Bulletin Du Cancer|July 29, 2006
[Neoadjuvant chemotherapy and ovarian cancer]Isabelle Ray-Coquard, Chadi Saba, Thomas Bachelot, et al.
Plos One|August 4, 2009
Development and validation of a bedside score to predict early death in cancer of unknown primary patientsNicolas Penel, Sylvie Negrier, Isabelle Ray-Coquard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 2, 2023
Do surgeons overestimate diaphragmatic peritoneal disease in interval debulking surgery of ovarian cancer?Estelle Turrel, Nicolas Chopin, Pierre Meeus, et al.
Clinical Pharmacology : Advances and Applications|December 4, 2012
Pazopanib for the treatment of soft-tissue sarcomaPierre Heudel, Philippe Cassier, Olfa Derbel, et al.
Bulletin Du Cancer|April 3, 2016
[Innovative anticancer agents reserved to hospital use and not involved in the hospital budget: Creation and evolution]Gilles Freyer, Michel Marty, , et al.
Bulletin Du Cancer|June 2, 2015
[Initial management of advanced ovarian cancer: What radiological, pathological and surgical information are important for optimal therapeutic strategy?]Pierre-Etienne Heudel, Frédéric Selle, Philippe Morice, et al.
Pageof 55

Showing results (131-140 of 548) with videos related to

Sort By:
Pageof 55
The Oncologist|January 23, 2025
Ovarian clear cell carcinoma: open questions on the management and treatment algorithmRoberta Rosso, Margherita Turinetto, Fulvio Borella, et al.
Plos One|June 9, 2022
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopeniaGerald A Soff, Isabelle Ray-Coquard, Luis J Marfil Rivera, et al.
Bulletin Du Cancer|January 20, 2012
First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancerJulien Peron, Olivier Tredan, Isabelle Ray-Coquard, et al.
Bulletin Du Cancer|November 23, 2011
[Renal insufficiency and breast cancer]Philippe Beuzeboc, Christophe Le Tourneau, Joseph Gligorov, et al.
Bulletin Du Cancer|July 29, 2006
[Neoadjuvant chemotherapy and ovarian cancer]Isabelle Ray-Coquard, Chadi Saba, Thomas Bachelot, et al.
Plos One|August 4, 2009
Development and validation of a bedside score to predict early death in cancer of unknown primary patientsNicolas Penel, Sylvie Negrier, Isabelle Ray-Coquard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 2, 2023
Do surgeons overestimate diaphragmatic peritoneal disease in interval debulking surgery of ovarian cancer?Estelle Turrel, Nicolas Chopin, Pierre Meeus, et al.
Clinical Pharmacology : Advances and Applications|December 4, 2012
Pazopanib for the treatment of soft-tissue sarcomaPierre Heudel, Philippe Cassier, Olfa Derbel, et al.
Bulletin Du Cancer|April 3, 2016
[Innovative anticancer agents reserved to hospital use and not involved in the hospital budget: Creation and evolution]Gilles Freyer, Michel Marty, , et al.
Bulletin Du Cancer|June 2, 2015
[Initial management of advanced ovarian cancer: What radiological, pathological and surgical information are important for optimal therapeutic strategy?]Pierre-Etienne Heudel, Frédéric Selle, Philippe Morice, et al.
Pageof 55